A detailed history of Franklin Street Advisors Inc transactions in Infla Rx N.V. stock. As of the latest transaction made, Franklin Street Advisors Inc holds 75,100 shares of IFRX stock, worth $193,758. This represents 0.01% of its overall portfolio holdings.

Number of Shares
75,100
Previous 75,100 -0.0%
Holding current value
$193,758
Previous $131,000 12.21%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$1.25 - $2.75 $31,250 - $68,750
25,000 Added 49.9%
75,100 $122,000
Q2 2023

Jul 13, 2023

SELL
$2.05 - $6.1 $51,249 - $152,500
-25,000 Reduced 33.29%
50,100 $223,000
Q1 2021

May 04, 2021

BUY
$3.62 - $6.34 $181,000 - $317,000
50,000 Added 199.2%
75,100 $293,000
Q4 2020

Feb 01, 2021

BUY
$3.82 - $5.32 $95,882 - $133,532
25,100 New
25,100 $126,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $114M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.